Postdoc opening to work on @OHDSI pharmaco-epi projects with myself and others at Johns Hopkins Center for Drug Safety and Effectiveness: https://t.co/YXm0QsRpY8
If interested, email or catch me at the OHDSI symposium this week!
Join us in advancing data science and AI research! The Johns Hopkins Data Science and AI Institute Postdoctoral Fellowship Program is now accepting applications for the 2026–2027 academic year. Apply now! Deadline: Jan 23, 2026. Details and apply: https://t.co/bdxrDTzc4Q
Celebrating Yuzheng Dun's successful defense @jhubiostat (co-advised by @nilanjan10c and me) at the famed Mama Chang near DC. Joy to work with you and see you come out with an impressive PhD thesis, Yuzheng! Looking forward to seeing what you accomplish next with @wu_biostat 😉
And here's the second in the series, significantly generalizing the HMC-PDMP connection suggested by the first: https://t.co/iF7ZYE33vZ
The third is to be arXived soon and extends the connection to the "sticky" algorithms for posterior inference under spike-and-slab priors.
Our paparazzi article on the secret kinship between HMC and PDMP is now officially out! https://t.co/VfcJThZrs4
This is the first in a series of work showing PDMP to be essentially a version of (bouncy) HMC, shedding light on their relative strengths and limitations.
Congrats to Fan and other Blackwell-Rosenbluth awardees for well-deserved recognition. And thank you @j_ISBA and the award committee for making this award possible. It's so important for the @ISBA_events community to continue recognizing contributions of our junior researchers!
US election might be occupying much of everyone's mind nowadays, but let's not forget about other important elections. Like the @ISBA_events one to elect new board members for your own communities!
(Fwiw, yours truly is running for "Bayesian Computation Secretary.")
Congrats to @rohan_khera, his team at Yale, and all the @OHDSI collaborators for delivering this landmark evidence on diabetes drugs. It's been a huge honor to be involved in the LEGEND initiative and working with y'all.
The LEGEND-T2DM team studied the effectiveness of several types of diabetes medications to reduce cardiovascular events across nearly 1.5 million patients. Check out the @JACCJournals study ⬇️ #JoinTheJourney@suchard_group
https://t.co/z7DzTK1XYr
Very exciting to have our paper featured in the National Eye Institute's latest challenge, as a pioneering work bringing the power of @OHDSI to ophthalmology: https://t.co/5V4EJh2TES
Congrats @ CindyCai and the team; let's continue our Heraculian efforts to save more Sisyphuses
Announcing @jhubiostat reception Mon, Aug 5th at #JSM2024! 🥂🎉 8 - 10pm @ Skybox Deck of Garden Tavern: https://t.co/K6NISTnuqX.
The venue is part of the @cartsidepdx food cart pod, so you can also grab a pre-reception dinner from food carts for an iconic Portland experience!
Looking forward to sharing my latest work at @j_ISBA's Blackwell-Rosenbluth awardee session at #jsm2024. Our *bouncy* HMC unifies HMC and PDMP, two cutting-edge paradigms in Bayesian computation: https://t.co/iF7ZYE2vGr.
Big thanks to @Bea_Franzo &
@FannyBu214 for organizing!
My first foray into polygenic risk score w/ awesome statsgen colleagues @nilanjan10c & @Jin_10ustc: https://t.co/khTYrp2Eza. Turns out the commonly-used approx likelihood can give rise to an improper posterior! (We present a fix.) It won @YuzhengDun an ASA student paper award 🎉
Another job posting! This time for finance staff folks.
@jhubiostat is looking for a Sr. Grants and Contracts Analyst to provide support on pre-award and post-award functions. Join us!
https://t.co/ShyFXuiSxa
Congratulations to lead author Fan Bu and the team on the recent publication in Statistics in Medicine: Bayesian safety surveillance with adaptive bias correction. @suchard_group@kricketchirps@_aki_nishimura
https://t.co/kQrPsJh8zQ
Join us at @warwickstats! We are advertising for 5 Assistant Professors (3 in Statistics; 2 in Computational Statistics or Machine Learning) and one Associate Professor. Details at https://t.co/qfj6gPLlql
Glad to see my academic sister @FannyBu214 from Duke Stats/UCLA Biostats already emerging as an important figure. She must have caught the same save-the-world-with-biostats bug from @suchard_group 🙃
In @BMJMedicine, we report the largest federated pharmacoepi study of 2nd line diabetes drugs in CV disease
Multinational - with 4.8 million ppl - but w/o pt data sharing across sites!
A new way to epi - details in 🧵
w @suchard_group#LEGEND Team
https://t.co/LTbmBmxL3W